Inventor · disambiguated record
Weichao George Chen
Also filed as: CHEN WEICHAO · CHEN WEICHAO G · CHEN WEICHAO GEORGE
16 granted patents·12 pending applications·114 citations·filing 2001–2024
92Inventor score
Top patents by PatentIndex Score
28 records- 0195US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 0294US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 0394US11155533B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Oct 26, 2021·10 cites·13 claims
- 0493US10654829B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2018·Granted May 19, 2020·21 cites·23 claims
- 0592US11517564B2Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2018·Granted Dec 6, 2022·8 cites·26 claims
- 0692US11179367B2Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2019·Granted Nov 23, 2021·18 cites·13 claims
- 0792US10668033B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Jun 2, 2020·4 cites·32 claims
- 0891US8895776B2Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2009·Granted Nov 25, 2014·23 cites·98 claims
- 0988US11253509B2Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2018·Granted Feb 22, 2022·9 cites·21 claims
- 1086US2025009693A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2024·Application pending·0 cites
- 1184US12186306B2Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2021·Granted Jan 7, 2025·2 cites·22 claims
- 1282US2023404954A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2023·Application pending·0 cites
- 1381USRE50267EModulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2022·Granted Jan 14, 2025·0 cites·35 claims
- 1479US2023121825A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2022·Application pending·0 cites
- 1578US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1677US2025099425A1Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1774US12350262B2Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2022·Granted Jul 8, 2025·0 cites·4 claims
- 1869US2020375930A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 1968US6830897B2High throughput screen for reducing drug candidate attritionPFIZER·Filed 2001·Granted Dec 14, 2004·3 cites·8 claims
- 2067US2025288563A1Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2166US2022257564A1Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2263US2015126527A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2014·Application pending·0 cites
- 2359US2021340133A1Modulators of the gpr119 receptor and the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2459US2013217706A1Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related theretoTRAN THUY-ANH·Filed 2012·Application pending·0 cites
- 2557US10894787B2Modulators of the GPR119 receptor and the treatment of disorders related theretoJONES ROBERT M·Filed 2011·Granted Jan 19, 2021·0 cites·35 claims
- 2653US2022047564A1Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 2751US7776891B2VLA-4 antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Aug 17, 2010·0 cites·2 claims
- 2843US6852733B2Sodium-hydrogen exchanger type 1 inhibitorPFIZER·Filed 2001·Granted Feb 8, 2005·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Weichao George Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →